Infinion Biopharma
VC Fund
Ahmedabad, India
Infinion Biopharma is a research-driven, vertically integrated biopharmaceutical company.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Infinion Biopharma invests in
Stages Infinion Biopharma invests in
Countries Infinion Biopharma invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
GAUTAM BALI
|
|||
|
GOVINDSINGH BHAVANSINH CHAVDA
|
|||
|
NARENDRASINH PRAHLADSINH DEVDA
|
|||
|
VISHAL HARSHVARDHAN JAIN
|
|||
Investment Focus
Industry
- Health Care 1 (100%)
- Biotechnology 1 (100%)
- Pharmaceutical 1 (100%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
GAUTAM BALI
Director
|
Director | Total investments: 0 | Find email | |
|
GOVINDSINGH BHAVANSINH CHAVDA
Director
|
Director | Total investments: 0 | Find email | |
|
NARENDRASINH PRAHLADSINH DEVDA
Managing Director
|
Managing Director | Total investments: 0 | Find email | |
|
VISHAL HARSHVARDHAN JAIN
Director
|
Director | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
AURUM Biosciences Ltd develops novel pharmaceuticals for use in a number of different clinical indications of high unmet medical need. Aurum is currently completing preclinical development of ABL101, its lead stroke management product, and envisages initiating clinical studies of efficacy and safety in the near future. Follow-on programmes includeproducts for heart disease, cancer, epilepsy, and dementia. Aurum’s lead project utilises an oxygen carrier and proprietary software for use with MRI in Acute Ischaemic Stroke. Aurum has funding in place to initiate recruitment for a Phase 2 clinical study in stroke patients. | $875.3K / Oct 12, 2020 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Infinion Biopharma invest in?
Infinion Biopharma invests primarily in Health Care, Biotechnology and Pharmaceutical startups, most often at Funding Round stage. Most of the 1 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Infinion Biopharma?
Public channels for Infinion Biopharma include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Infinion Biopharma?
The team at Infinion Biopharma includes GAUTAM BALI (Director), GOVINDSINGH BHAVANSINH CHAVDA (Director) and NARENDRASINH PRAHLADSINH DEVDA (Managing Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!